David Satijn
Impact in
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- RNA Research and Splicing
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Epigenetics and DNA Methylation 16
- Cancer-related gene regulation 14
- RNA modifications and cancer 8
- Genomics and Chromatin Dynamics 3
-
- Monoclonal and Polyclonal Antibodies Research 14
- Co-authors
- Arie P. Otte (18 shared papers)Karien M. Hamer (10 shared papers)Marco J. Gunster (5 shared papers)Johan van der Vlag (4 shared papers)Richard G. A. B. Sewalt (5 shared papers)Elly Fieret (4 shared papers)Frank M. Raaphorst (4 shared papers)Roel van Driel (4 shared papers)
- Journals
- Molecular and Cellular Biology (7 papers)Blood (4 papers)The Journal of Immunology (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- NetherlandsUnited StatesDenmark
In The Last Decade
David Satijn
34 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 2.2k
- Oncology 616
- Immunology 314
- Radiology, Nuclear Medicine and Imaging 296
- Genetics 381
Countries citing papers authored by David Satijn
This map shows the geographic impact of David Satijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Satijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Satijn more than expected).
Fields of papers citing papers by David Satijn
This network shows the impact of papers produced by David Satijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Satijn. The network helps show where David Satijn may publish in the future.
Co-authors
The 25 scholars most cited alongside David Satijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 242 | |
| 2 | 2001 | 227 | |
| 3 | 1998 | 201 | |
| 4 | 2013 | 178 | |
| 5 | 1999 | 172 | |
| 6 | 2018 | 169 | |
| 7 | 1997 | 168 | |
| 8 | 2001 | 151 | |
| 9 | 1997 | 146 | |
| 10 | 2008 | 140 | |
| 11 | 2000 | 139 | |
| 12 | 1997 | 136 | |
| 13 | 2016 | 111 | |
| 14 | 1999 | 110 | |
| 15 | 1999 | 107 | |
| 16 | 1997 | 103 | |
| 17 | 2003 | 102 | |
| 18 | 2000 | 84 | |
| 19 | 2015 | 82 | |
| 20 | 2001 | 62 |
About David Satijn
David Satijn is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Immunology and Allergy, having authored 36 papers that have together received 3.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (16 papers), Cancer-related gene regulation (14 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), RNA modifications and cancer (8 papers), HER2/EGFR in Cancer Research (7 papers), Cell Adhesion Molecules Research (5 papers), Genomics and Chromatin Dynamics (3 papers) and Phagocytosis and Immune Regulation (3 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Oncology (616 citations), Immunology (314 citations), Radiology, Nuclear Medicine and Imaging (296 citations) and Genetics (381 citations). David Satijn has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Arie P. Otte, Karien M. Hamer, Marco J. Gunster, Johan van der Vlag, Richard G. A. B. Sewalt, Elly Fieret, Frank M. Raaphorst, Roel van Driel, Chris J.L.M. Meijer and Folkert J. van Kemenade. Their work appears in journals such as Molecular and Cellular Biology, Blood, The Journal of Immunology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.